Replacement of proteins by the artificial small-sized dimeric macrocycles seems to have advantages for drug development, such as production by chemical synthesis and amenability to chemical modifications for the control of pharmacokinetics, protease resistance and drug delivery, and such controlled properties should be carefully evaluated in future research and development
As the Founder and Academic Chairman of the Seeds Scientific Research & Performance (SSRP) Institute, he leads the field in Cellular Medicine and Epigenetics, bringing cutting-edge research to the forefront of patient care
Notably, recent evidence reveals that EGCs could possess multiple immune functions and thereby may participate in the immune homeostasis of the gut [186]
Acknowledgments The corresponding author, AS, is thankful to authors for their collaborative efforts in writing this paper
This is not vanity biology
It all comes down to absorption